← Back to Search

sipIT Intervention for Kidney Stones

N/A
Waitlist Available
Led By Necole M Streeper, MD
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 3 months, and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if using tech tools to monitor water intake can help people with a history of kidney stones better follow their doctor's recommended water consumption.

Who is the study for?
This trial is for English-speaking adults over 18 who've had a kidney stone in the last 5 years, can use a smartphone, and are willing to wear a Fitbit daily for a year. They should drink less than 2 liters of fluid per day. It's not for pregnant women or those planning pregnancy, people moving away or having surgery soon, on certain medical treatments, with specific health conditions that affect fluid intake or urine collection.
What is being tested?
The sipIT study tests if tools like wrist sensors, smart water bottles, and apps can help people with past kidney stones follow doctor's advice on drinking enough fluids. Participants will use these tech aids to see if they improve their hydration habits.
What are the potential side effects?
There may be no direct side effects from using the sipIT tools themselves; however, increasing fluid intake could potentially lead to more frequent urination. People with certain health conditions might have risks associated with higher fluid consumption.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 3 months, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 3 months, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
24-hr urine volume
Secondary study objectives
Habit strength for fluid intake
Past-week fluid intake
Urine supersaturations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: sipITExperimental Treatment1 Intervention
Participants receive education and a digital tool to monitor their fluid intake and remind them when they have lapsed in regular fluid intake.
Group II: ControlActive Control1 Intervention
Participants receive usual care (i.e., education about fluid intake guidelines and encouragement to meet those guidelines).

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
369 Previous Clinical Trials
127,381 Total Patients Enrolled
3 Trials studying Kidney Stones
3,594 Patients Enrolled for Kidney Stones
Necole M Streeper, MDPrincipal InvestigatorMedical College of Wisconsin
David E Conroy, PhDPrincipal InvestigatorThe Pennsylvania State University
4 Previous Clinical Trials
553 Total Patients Enrolled

Media Library

sipIT Clinical Trial Eligibility Overview. Trial Name: NCT05196113 — N/A
Kidney Stones Research Study Groups: sipIT, Control
Kidney Stones Clinical Trial 2023: sipIT Highlights & Side Effects. Trial Name: NCT05196113 — N/A
sipIT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05196113 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top